Companies

Graph Therapeutics

graphtx.com

An AI-powered techbio platform for precision drug discovery in inflammation and immunology.

Employees11-50
FundingOver $10M
2 active roles
Healthcare AIAI ApplicationAPI / PlatformSeed$10M-$50M

About

Graph Therapeutics builds an AI-powered lab-in-the-loop platform for precision drug discovery in inflammation and immunology. They target pharmaceutical companies and biotech researchers by combining primary patient cell perturbation modeling with multi-omics data to identify high-impact drug targets. The company generates value by developing an internal precision therapeutics pipeline to treat immune-driven diseases.

Active Roles

2
Klosterneuburg/Other/Today
Klosterneuburg/Other/11d ago

Key Investors

Daphni, SquareOne, Merantix Capital, NAVEC Investment Management